**Question:** Parkinsonism differ from atypical parkinsonism by the absence of

A. levodopa responsiveness
B. dementia
C. rapid eye movement sleep behavior disorder (RBD)
D. levodopa-induced dyskinesias

**Correct Answer:** A. levodopa responsiveness

**Core Concept:** Parkinsonism and atypical parkinsonism are clinical syndromes characterized by motor symptoms due to the loss of dopaminergic neurons in the substantia nigra.

**Why the Correct Answer is Right:** Parkinsonism typically refers to the classical form of Parkinson's disease, which primarily involves the loss of dopaminergic neurons in the substantia nigra and presents with the classical motor symptoms such as tremors, bradykinesia, rigidity, and postural instability. Levodopa is a dopaminergic precursor that crosses the blood-brain barrier and is converted into dopamine in the brain. Hence, patients with Parkinsonism are typically responsive to levodopa therapy.

**Why Each Wrong Option is Incorrect:**

B. Dementia is a cognitive impairment that is not a core feature of Parkinsonism. Although dementia may coexist in some Parkinson's disease cases, it is not a defining feature that differentiates Parkinsonism from atypical parkinsonism.

C. Rapid eye movement sleep behavior disorder (RBD) is a parasomnia characterized by excessive motor activity during sleep, often associated with degenerative neurological conditions like Parkinson's disease and multiple system atrophy. While RBD can be seen in both Parkinsonism and atypical parkinsonism, it is not a defining feature that distinguishes the two conditions.

D. Levodopa-induced dyskinesias are involuntary movements that occur as a result of long-term levodopa therapy in patients with Parkinson's disease. Unlike Parkinson's disease, atypical parkinsonism often presents with dyskinesias in response to levodopa therapy.

**Clinical Pearl:** The differential diagnosis between Parkinsonism and atypical parkinsonism is essential since the treatment and prognosis differ significantly. Parkinson's disease patients typically respond well to dopaminergic therapy like levodopa, while atypical parkinsonism patients often do not respond as well and may require alternative treatment strategies like dopamine agonists or monoamine oxidase B inhibitors.